Abstract

BackgroundThis article is a duplicated publication from the Japanese version of “2019 JSDT Guidelines for Peritoneal Dialysis” with permission from the Japanese Society for Dialysis Therapy (JSDT). This clinical practice guideline (CPG) was developed primarily by the Working Group on Revision of Peritoneal Dialysis (PD) Guidelines of the Japanese Society for Dialysis Therapy. Recently, the definition and creation process for CPGs have become far more rigorous; traditional methods and formats no longer adhere to current standards. To improve the reliability of international transmission of our findings, CPGs are created in compliance with the methodologies developed by the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) working group. Part 2 of this PD guideline is the first CPG developed by our society that conforms to the GRADE approach.MethodsDetailed processes were created in accordance with the Cochrane handbook and the GRADE approach developed by the GRADE working group.ResultsClinical question (CQ)1: Is the use of renin-angiotensin system inhibitors (RAS inhibitors), such as angiotensin-converting enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARB), effective in PD patients?Recommendation: We suggest the usage of RAS inhibitors (ACEI and ARB) in PD patients (GRADE 2C).CQ2: Icodextrin or glucose solution: which is more useful as a dialysate among patients with PD?Recommendation: We suggest using icodextrin when managing body fluids in PD patients (GRADE 2C).CQ3: Is it better to apply or not apply mupirocin/gentamicin ointment to the exit site?Recommendation: We suggest not applying mupirocin/gentamicin ointment to the exit sites of PD patients (GRADE 2C).CQ4: Which surgical approach is more desirable when a PD catheter is placed, open surgery or laparoscopic surgery?No recommendation.CQ5: Which administration route of antibiotics is better in PD patients with peritonitis, intravenous or intraperitoneal?Recommendation: We suggest intraperitoneal administration of antibiotics in PD patients with peritonitis (GRADE 2C).Note: The National Insurance does not currently cover intraperitoneal administration.CQ6: Is peritoneal dialysis or hemodialysis better as the first renal replacement therapy in diabetic patients?No recommendation.ConclusionsIn the future, we suggest that society members construct their own evidence to answer CQs not brought up in this guideline, and thereby show the achievements of Japan worldwide.

Highlights

  • Recommendation: We suggest the usage of Renin-angiotensin system (RAS) inhibitors (ACEI and angiotensin receptor blockers (ARB)) in Peritoneal Dialysis (PD) patients (GRADE 2C)

  • CQ2: Icodextrin or glucose solution: which is more useful as a dialysate among patients with PD? Recommendation: We suggest using icodextrin when managing body fluids in PD patients (GRADE 2C)

  • CQ5: Which administration route of antibiotics is better in peritoneal dialysis patients with peritonitis, intravenous or intraperitoneal? Recommendation: We suggest intraperitoneal administration of antibiotics in PD patients with peritonitis (GRADE 2C)

Read more

Summary

Results

Clinical question (CQ): Is the use of renin-angiotensin system inhibitors (RAS inhibitors), such as angiotensin-converting enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARB), effective in PD patients? Recommendation: We suggest the usage of RAS inhibitors (ACEI and ARB) in PD patients (GRADE 2C). Recommendation: We suggest using icodextrin when managing body fluids in PD patients (GRADE 2C). CQ3: Is it better to apply or not apply mupirocin/gentamicin ointment to the exit site? Recommendation: We suggest not applying mupirocin/gentamicin ointment to the exit sites of PD patients (GRADE 2C). CQ5: Which administration route of antibiotics is better in PD patients with peritonitis, intravenous or intraperitoneal? Recommendation: We suggest intraperitoneal administration of antibiotics in PD patients with peritonitis (GRADE 2C). CQ6: Is peritoneal dialysis or hemodialysis better as the first renal replacement therapy in diabetic patients? CQ6: Is peritoneal dialysis or hemodialysis better as the first renal replacement therapy in diabetic patients? No recommendation

Background
Summary of recommendations
Methods
B: Moderate
D: Very low
RCT Serious Not serious Serious k
RCT Not Not serious Not serious Serious q None serious
Study design
RCT Serious Not serious Very serious Very
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call